{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:56:12Z","timestamp":1790006172906,"version":"4.0.1"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Pirfenidone [5-methyl-1-phenyl-2-(1H)-pyridone] down-regulates expression of cytokines and other mediators involved in the onset and development of pulmonary fibrosis. Pirfenidone also inhibits production of tumor necrosis factor alpha (TNF-\u03b1) from macrophages incubated with endotoxin and protects mice against endotoxin shock. Pirfenidone's ability to reduce cytokine expression in these disorders led us to investigate the drug's effect on another cytokine anomaly, superantigen-induced shock. BALB\/c mice were exposed to staphylococcal enterotoxin B (SEB) either systemically or by aerosol and subsequently potentiated with a sublethal dose of lipopolysaccharide. In these experiments, pirfenidone given 2 to 4.25 h after SEB resulted in 80 to 100% survival versus only 0 to 10% survival among untreated control animals. Relative to serum cytokine levels from controls given toxin but no drug, there was a 35 to 80% decrease in TNF-\u03b1, interleukin 1, and other proinflammatory cytokines. In vitro experiments with human peripheral blood lymphocytes revealed that pirfenidone reduced SEB-induced cytokine levels 50 to 80% and inhibited 95% of SEB-induced T-cell proliferation. Overall, these studies demonstrated the potential utility of pirfenidone as a therapeutic against septic shock and the biological effects of SEB.<\/jats:p>","DOI":"10.1128\/iai.70.6.2989-2994.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:09:29Z","timestamp":1027764569000},"page":"2989-2994","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":46,"title":["Pirfenidone Blocks the In Vitro and In Vivo Effects of Staphylococcal Enterotoxin B"],"prefix":"10.1128","volume":"70","author":[{"given":"Martha L.","family":"Hale","sequence":"first","affiliation":[{"name":"Toxinology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon B.","family":"Margolin","sequence":"additional","affiliation":[{"name":"Marnac, Inc., Dallas, Texas 75225"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Krakauer","sequence":"additional","affiliation":[{"name":"Toxinology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad J.","family":"Roy","sequence":"additional","affiliation":[{"name":"Toxinology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley G.","family":"Stiles","sequence":"additional","affiliation":[{"name":"Toxinology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.4049\/jimmunol.144.12.4501","volume":"144","year":"1990","unstructured":"Alber, G., D. K. Hammer, and B. Fleischer. 1990. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J. Immunol.144:4501-4506.","journal-title":"J. Immunol."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/74672"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Beno D. W. M. R. Uhing M. Goto Y. Chen V. A. Jiyamapa-Serna and R. E. Kimura. 2001. Staphylococcal enterotoxin B potentiates LPS-induced hepatic dysfunction in chronically catheterized rats. Am. J. Physiol. Gastrointest. Liver Physiol. 5: G866-G872.","DOI":"10.1152\/ajpgi.2001.280.5.G866"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270405"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)01863-4"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(98)00042-3"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/72262"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.1.79"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00041-8"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.22.8941"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc711"},{"key":"e_1_3_1_13_2","unstructured":"Department of Health and Human Services. 1985. Guide for the care and use of laboratory animals revised ed. NIH publication no. 86-23. Department of Health and Human Services Washington D.C."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.57.1.291-294.1989"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.4049\/jimmunol.161.10.5627","volume":"161","year":"1998","unstructured":"Fujisawa, N., S. Hayashi, A. Kurdowska, J. M. Noble, K. Naitoh, and E. J. Miller. 1998. Staphylococcal enterotoxin A injury of human lung endothelial cells and IL-8 accumulation are mediated by TNF-\u03b1. J. Immunol.161:5627-5632.","journal-title":"J. Immunol."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.1.391"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<1021::AID-IMMU1021>3.0.CO;2-3"},{"key":"e_1_3_1_18_2","first-page":"367","volume":"291","year":"1999","unstructured":"Iyer, S. N., G. Gurujeyalakshmi, and S. N. Giri. 1999. Effects of pirfenidone on transforming growth factor-\u03b2 gene expression at the transcriptional level in bleomycin model of lung fibrosis. J. Pharmacol. Exp. Ther.291:367-373.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_1_19_2","first-page":"779","volume":"125","year":"1995","unstructured":"Iyer, S. N., J. S. Wild, M. J. Schiedt, D. M. Hyde, S. B. Margolin, and S. N. Giri. 1995. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J. Lab. Clin. Med.125:779-785.","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-198-43321A"},{"key":"e_1_3_1_21_2","first-page":"72","volume":"113","year":"1998","unstructured":"Kaneko, M., H. Inoue, R. Nakazawa, N. Azuma, M. Suzuki, S. Yamauchi, S. B. Margolin, K. Tsubota, and I. Saito. 1998. Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin. Exp. Immunol.113:72-76.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.2.387"},{"key":"e_1_3_1_23_2","first-page":"34","volume":"98","year":"1997","unstructured":"Kasai, T., K. Inada, T. Takakuwa, Y. Yamada, Y. Inoue, T. Shimamura, S. Taniguchi, S. Sato, G. Wakabayashi, and S. Endo. 1997. Anti-inflammatory cytokine levels in patients with septic shock. Res. Commun. Mol. Pathol. Pharmacol.98:34-42.","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02786471"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.6.4.594-598.1999"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/019262339602400513"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(95)03202-Q"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00237-9"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2185544"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230715"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.1.91"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007023532508"},{"key":"e_1_3_1_33_2","first-page":"1861","volume":"158","year":"1997","unstructured":"Neuman, B., B. Engelhardt, H. Wagner, and B. Holzmann. 1997. Induction of acute inflammatory lung injury by staphylococcal enterotoxin B. J. Immunol.158:1861-1871.","journal-title":"J. Immunol."},{"key":"e_1_3_1_34_2","first-page":"262","volume":"83","year":"1994","unstructured":"Neuner, P., G. Klosner, E. Schauer, M. Pourmojib, W. Macheiner, C. Grunwald, R. Knobler, A. Schwarz, T. A. Luger, and T. Schwarz. 1994. Pentoxifylline in vivo down regulates the release of IL-1-beta, IL-6, IL-8 and tumor necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology83:262-267.","journal-title":"Immunology"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00784.x"},{"key":"e_1_3_1_36_2","first-page":"646","volume":"4","year":"1977","unstructured":"Petit, G. W., M. R. Elwell, and P. B. Jahrling. 1977. Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. J. Infect. Dis.4:646-648.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_37_2","first-page":"1264","volume":"159","year":"1999","unstructured":"Raghu, G., W. C. Johnson, D. Lockhart, and Y. Mageto. 1999. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label phase II study. Am. J. Respir. Crit. Care Med.159:1264-1267.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(98)90127-5"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001090000086"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.12.5333-5338.1993"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.4.1229-1234.1995"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0940-2993(11)80261-7"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/114.2.111"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/330662a0"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1998.0376"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.24.5.4160"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90980-X"},{"key":"e_1_3_1_48_2","first-page":"121","volume":"3","year":"1991","unstructured":"Wood, A. C., I. Todd, A. Cockayne, and J. P. Arbuthnott. 1991. Staphylococcal enterotoxins and the immune system. FEMS Microbiol. Immunol.3:121-133.","journal-title":"FEMS Microbiol. Immunol."},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","unstructured":"Zhang S. I. A. Shiels J. S. Ambler and S. M. Taylor. 1998. Pirfenidone reduces fibronectin synthesis by cultured human retinal pigment epithelial cells. Aust. N. Z. Opthalmol. 26 (Suppl. 1) : S74-S76.","DOI":"10.1111\/j.1442-9071.1998.tb01380.x"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.6.2989-2994.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.6.2989-2994.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T16:04:17Z","timestamp":1682265857000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.70.6.2989-2994.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1128\/IAI.70.6.2989-2994.2002"],"URL":"https:\/\/doi.org\/10.1128\/iai.70.6.2989-2994.2002","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"2001-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}